Recorded Presentations from the NCCN 2025 Lung Cancer Congress

The NCCN 2025 Lung Cancer Congress is designed to provide the interprofessional oncology care team with practical guidance on the latest updates to the NCCN Guidelines, novel and emerging therapies, recent clinical research, and strategies to align new developments with current standards of care. This activity aims to support the implementation of evidence-based, team-driven approaches to improve outcomes for patients with lung cancer, particularly in community-based practice.

Target Audience

This program is designed to meet the educational needs of physicians, nurse practitioners, nurses, pharmacists, physician associates, and other relevant health care professionals who treat patients with lung cancer.

Learning Objectives

The goal for NCCN continuing education is to enhance patient care and outcomes by improving the competence and performance of clinicians.

The goal of the program is to ensure that members of the interprofessional oncology care team have the knowledge and skills necessary to:

  • Apply the current standards of oncology care and key updates in the NCCN Guidelines to optimize the management of patients with lung cancer.
  • Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with lung cancer.
  • Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with lung cancer.
Additional information
Disclosures: 
Supporters: 

This activity is supported by educational grants from:

  • Exact Sciences
  • Genentech, a member of the Roche Group
  • Johnson & Johnson

This activity is supported by independent medical education grants from: 

  • AbbVie
  • Boehringer Ingelheim Pharmaceuticals, Inc.
Course summary
Course opens: 
12/15/2025
Course expires: 
12/14/2026
Cost:
$50.00

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Click here to download the faculty disclosures for this program.

This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.

Complete accreditation information is provided for each individual educational activity.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.

Price

Cost:
$50.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for certificate viewing/printing